Clinical Care Toolkit
The recent development of novel biological and targeted agents has revolutionized the care of patients with rheumatoid arthritis (RA). With targeted treatment, RA patients have seen improvements in quality of life, better control of disease progression, and less joint damage and disability. Early diagnosis and treatment of RA can prevent or substantially slow progression of joint damage in the majority of patients. Remission may even be possible, particularly for patients with early RA. In order to improve patient outcomes and prevent RA-related disability, it is crucial for healthcare providers to remain up-to-date on changes to treatment guidelines, novel therapeutic approaches, and newly published clinical trial data. In this Provider Toolkit, you will find information to supplement your current knowledge of RA, including guidelines on diagnosis and treatment of RA, clinical trial data supporting the use of novel agents, and links to additional resources.